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Abstract. This study aimed to assess the characteristics, utilization of antihyperglycemic 
drugs, and to analyze the quality of life (QOL) in type 2 diabetes mellitus (T2DM) patients. 
This two-month prospective descriptive cross-sectional study was undertaken by 
distributing the European Quality of Life - 5 Dimensions 3 Level (EQ-5D-3L) questionnaire 
to the patients with T2DM  (n=50) admitted to Helvetia primary health center Medan to 
assessed their QOL. The patients‟ characteristics and the utilization of antihyperglycemic 
drugs were assessed from the patients‟ medical records using a self-designed questionnaire. 
The inclusion criteria were T2DM patients with age of 18 years or older,  had no mental 
disorders,  and agreed to sign the informed consent. The patients‟ characteristics, their QOL, 
utilization of antihyperglycemic drugs, and association among their characteristics and QOL 
were analyzed using descriptive and Chi-Square tests. All analyses were performed using 
the Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p 
value <0.05 was considered significant). It was found that the mean age of the T2DM 
patients was 59.70 ± 10.44 (years). Most (66%) of them were females. Majority (80%) of 
the patients graduated from primary to senior high schools.  Nearly half (44%) of the 
patients was provided glibenclamide. The mean QOL of the patients was 0.79 ± 0.14. There 
was no significant association between the patients‟ QOL and their characteristics (p values 
>0.05). This study proved that most of the T2DM patients were females. Glibenclamide was 
the most frequently prescribed drug for the patients. The QOL of the patients was 79% of 
full health. 
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Abstrak.  Penelitian ini bertujuan untuk mengakses karakteristik, penggunaan 
antihiperglikemia, dan menganalisis kualitas hidup atau quality of life (QOL) penderita 
diabetes mellitus tipe 2 (T2DM). Studi prospective descriptive cross-sectional ini dilakukan 
dengan mendistribusikan kuesioner the European Quality of Life - 5 Dimensions 3 Level 
(EQ-5D-3L) kepada pasien T2DM  (n=50) yang berobat selama periode 2 bulan ke 
Puskesmas Helvetia Medan untuk memperoleh QOL pasien. Karakteristik dan pola 
penggunaan antihiperglikemia diakses dari  rekam medik pasien menggunakan kuesioner 
yang didesain sendiri. Kriteria inklusi yaitu penderita T2DM umur 18 tahun atau lebih, 
tidak ada ganguan mental,  dan setuju menandatangani informed consent. Karakteristik 
dan QOL pasien, pola penggunaan obat, serta hubungan antara karakteristik dengan QOL 
pasien dianalisis secara deskriptif  dan tes Chi-Square. Semua analisis dilakukan 
menggunakan Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, 
USA) (p value <0.05 dinilai signifikan). Hasil penelitian membuktikan bahwa usia 
penderita T2DM tersebut adalah 59.70 ± 10.44 (tahun). Sebagian besar (66%) dari pasien 
adalah perempuan. Mayoritas (80%) dari pasien berpendidikan sekolah menengah 
pertama dan sekolah menengah atas.  Hampir setengah (44%) dari pasien diberi 
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glibenclamide. Nilai QOL pasien adalah 0.79 ± 0.14. Tidak ada hubungan yang signifikan 
antara QOL dengan karakteristik pasien (p>0.05). Penelitian ini membuktikan bahwa 
umumnya penderita T2DM adalah perempuan. Glibenclamide paling banyak diresepkan 
untuk pasien T2DM. Kualitas hidup pasien tersebut mencapai 79% dari sempurna. 
Kata kunci: Antihiperglikemia, EQ-5D, QOL, T2DM. 
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1. Introduction 
Diabetes mellitus (DM) remains as a global public health problem with continued increasing 
prevalence in developed as well as developing countries, including Indonesia. The disease 
contributed to 1.5 million of deaths worldwide in 2012. According to World Health 
Organization (WHO), the global prevalence of diabetes has nearly doubled since 1980, rising 
from 4.7% to 8.5% in 2014. The number of adults with DM in 2014 reached 422 million 
compared to those in 1980 was only 108 million. In Indonesia, it was found that 99,400 
incidences of death in patients with diabetes out of 258 million of the population. The disease 
contributed to 6% of the overall mortality in 2014 [1]. 
 
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia associated with 
abnormalities in the metabolism of carbohydrates, fats and proteins caused by decreased insulin 
secretion, decreased insulin activity or both which ultimately causes multiple medical 
complications, including nephropathy, retinopathy with potential blindness, neuropathy, 
gastrointestinal symptoms, amputation, impotence, symptomatic hyperglycemia, and 
hypoglycemia [2]. These conditions have resulted in reduced QOL and work productivity, 
which even finally leads to lower life expectancy. The disease will accompany the patient‟s 
lifetime and worsen over time if not treated properly[3]. Many complicated factors are 
associated with the QOL in patients with T2DM including age, gender, educational level, 
socioeconomic status, the disease duration, long-term multiple complications of DM, ability of 
the patients to cope with her or his diseases, and the provided health cares. These issues are the 
challenges of the health care systems in the international as well as national level[4, 5]. 
 
Varieties of health care programs in the management of DM have been implemented in different 
parts of the world. Yet, the health care programs should always be evaluated, analyzed, and 
improved in optimizing the scarce health resources and the public demand for health services. A 
pharmacoeconomic study plays a crucial role to evaluate the health care programs in the 
treatment of DM. One of the most important issues in this area is how to measure, value and 
incorporate changes in QOL into the economic evaluation. Therefore, the QOL as an outcome 
measure in the management of patients with T2DM must be studied [6]. 
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Many studies on QOL in T2DM patients with different methods and extents have been 
undertaken by researchers elsewhere. A large scale study had been undertaken to characterize 
the impact of hypoglycemia on diabetes burden, QOL, and work productivity from the patients‟ 
perspective. This study indicated that hypoglycemia negatively impacts social function, overall 
QOL, and work productivity [3]. Another study on QOL using WHO Diabetes Treatment 
Satisfaction Questionnaire (DTSQ) in patients with T2DM (n=180) conducted in a primary 
health center in Turkey found that their score was 21.02 ± 8.07 (range from better to worse: 36 
to 0) for the entire group [7]. Additionally, in a cross-sectional study, QOL of 183 patients with 
T2DM was analyzed using a questionnaire called the Audit of Diabetes Dependent Quality of 
Life (ADDQoL). It was indicated that the mean score of the patients‟ QOL was 0.98 ± 0.89 [8]. 
The characteristics of the patients with T2DM vary from one country to another due to 
differences in social economics status and health care systems which ultimately require different 
policies and approaches to optimize the disease management. 
 
In relation to the problems previously described, the present study was undertaken to assess the 
characteristics, utilization of antihyperglycemic drugs, and QOL inT2DM patients admitted to Helvetia 
primary health center. 
 
2. Methods 
This two-month prospective descriptive cross-sectional study was undertaken  to access the 
characteristics, utilization of antihyperglycemic drugs and the QOL of  patients with T2DM  
(n=50) admitted to Helvetia primary health center in Medan. This health center is included into 
one of the big five health centers with high patients‟ admission in this city. Thus, this center was 
chosen as the location of the study. The target population in this study was all patients suffered 
from T2DM admitted to Helvetia primary health center period June-July 2015. Patients with 
T2DM age 18 years or older, showed no mental disorder, and agreed to sign the inform consent 
were included into this study. The study was approved by Health Research Ethical Committee, 
Faculty of Medicine, University of Sumatera Utara, Indonesia. A self-designed questionnaire 
was used to access the patients‟ characteristics including gender, age, education, occupation, 
duration of the disease, complications and utilization of antihyperglycemic drugs from the 
patients‟ medical records.The QOL of each of the patients was assessed using EQ5D3L 
questionnaireas an instrument filled out by the patients with T2DM under the direction of the 
researchers [9]. The QOL of the patients assessed consisted of 5 dimensions including the 
patients‟ mobility, self care, usual activity, pain/discomfort and anxiety/depression). Each of the 
5 dimensions was categorized into 3 levels known as 3L (1= no problem, 2 = there is a bit 
problem, and 3 = there is a serious problem).The preferences of each patient were expressed as 
index value ranging from 11111 (full health or 100%) to 33333 (worst health or zero) using the 
EQ5D value set [9]. The patients‟ characteristics and mean value of their QOL were 
descriptively analyzed. The scores of the patients‟ QOL were categorized into three grades 
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(≥0.8 = good, <0.8-0.6 = fair, <0.6 = bad). Association among their characteristics and their 
QOL were analyzed using cross-tabulation Chi-Square test. All analyses were performed using 
the Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p value 
<0.05 was considered significant). 
 
 
3. Results 
In this study, there were 50 patients with T2DM recruited from the Helvetia health center period 
June-July 2015 that met the inclusion criteria. Characteristics of the patients with T2DM 
admitted to the primary health center are shown in Table 1. The mean age of the T2DM patients 
was 59.70 ± 10.44 (years). Most of them (66%) were females, whereas only 34 % of them were 
males.  
 
Table 1. Characteristics of the Patients with T2DM (n=50) Admitted to the Helvetia Primary 
Health Centre 
   Percentage (%) 
Gender Females 66 
 Males 34 
Age (years)  36-45 8 
46-55 28 
  56-65 32 
  >65 32 
Education Primary school 28 
  Junior high school 22 
  Senior high school 30 
  University 20 
Occupation Housewife 48 
Pensionary 20 
Enterpriser 18 
Official 8 
Teacher 6 
Duration of the disease ≤10 70 
  11-20  28 
  >20 2 
Complication Without       
complication 
42 
  With complication 58 
 
By age, 32% of the T2DM patients were in the age range of 56-65 years. The same proportion 
was also found in the patients aged older than 65 years.   More than a quarter (28%) of them 
were in the age range of 46-55 years. Only 8% of the patients werein the age range of 36-45 
years. The T2DM patients had different level of education. Nearly one third (30%) of them 
graduated from high schools. Twenty eight percent of them only graduated from primary 
schools. Less than a quarter (22%)of the T2DM patients graduated from junior high schools. 
Only 20% of them graduated from universities. With regard to occupation, nearly half (48%)of 
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the patients were housewives. The rest of the T2DM patients were pensionary (20%), 
enterprisers (18%), officials (8%), and teachers (6%). By duration of the disease, it was found 
that most of the patients (70%) have suffered from the disease for 0-10 years. Less than one 
third (28%) of them had suffered from the disease for 10-20 years.  Only 2% of them had 
suffered from the disease for more than 20 years. As much as 42% of the patients had no 
complications and more than half (58%) of them suffered from complications (58%). The 
utilization of antihyperglycemic drugs in the management of patients with T2DM at the 
Helvetia health center period June to July 2015 is listed in Table 2. 
Table 2. Utilization of Antihyperglycemic Drugs in The Management of Patients  
with T2DM (n=50) 
Drug utilized Proportion of the 
patients (%) 
Glibenclamide 44 
Glibenclamide-Metformin 18 
Glimepiride 16 
Metformin 12 
Glimepiride-Metformin 6 
Glimepiride-Glibenclamide 2 
Prodiabet-Metformin 2 
 
As listed in Table 2, the rank of antihyperglycemic drugs provided to the patients with T2DM in 
decreasing order were glibenclamide (44%), glibenclamide-metformin (18%), glimepiride 
(16%), metformin (12%), glimepiride-metformin(6%), glimepiride-glibenclamide (2%), and 
prodiabet-metformin (2%).  
 
The QOL of the patients with T2DM is demonstrated in Table 3. Overall, mean value of the 
QOL of the patients with T2DM was 0.79 ± 0.14. There were only 8 patients had perfect QOL. 
Five patients had QOL of 0.85. Majority (18) of the patients had the QOL dimensions of 11121 
with a score of 0.80. Thus, only 31 (62%) of them had good QOL.  Eighteen (36%) of them had 
fair QOL. One (2%) of the patients had bad QOL. 
Table 3. The QOL of Patients with T2DM (n=50) Based on the EQ5D 
Number of 
patients 
Mobility Self 
care 
Daily 
Activities 
Pain Depression Score (index 
value) per patient 
8  1 1 1 1 1 1 
5 1 1 1 1 2 0.85 
18 1 1 1 2 1 0.80 
14 1 1 1 2 2 0.73 
1 2 1 1 2 2 0.66 
1 2 1 2 1 2 0.74 
1 2 1 2 2 1 0.69 
1 2 1 2 2 2 0.62 
1 2 2 2 2 3 0.08 
 
Listed in Table 3 is the association between the age of the patients with T2DM and their QOL. 
It was proved that the QOL of the patients with T2DM was different in each age level.The 
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present study found that there was no significant difference between the QOL of males and 
those of females, p = 0.325. It was also proved that there was no significant association between 
the age of the patients and their QOL, p = 0.620. In other words, the age of the patients with 
T2DM did not affect their QOL. 
 
Table 4. Association Between the Characteristics and the QOL of the T2DM Patients 
Characteristics Number of the patients with QOL p 
Good  Fair Bad 
Gender Males 5 11 1 0.325 
Females 8 25 0  
Age group 
  
  
36-45 2 2 0 0.620 
46-55 3 9 1   
56-65 3 12 0  
 >65 5 13 0 
Education Primary school 4 10 0 0.377 
Junior high school 1 10 0 
Senior high school 5 10 0 
University 3 6 1 
Occupation Enterpriser 0 8 1 0.155 
Official 1 0 0 
Teacher 3 3 0 
Housewife 6 18 0 
Pensionary 3 7 0 
Duration of 
the disease 
(years) 
≤10  9 25 0 0.596 
11-20  4 10 1 
 
>20 0 1 0 
 Complication Without complication 7 14 0 0.446 
 
With complication 6 22 1 
 
The QOL of the patients with T2DM was not associated with their educations, p = 0.377. By 
occupation, the present study proved that there were no significant differences in QOL among 
the five groups of patients, p = 0.155. This study also indicated that there were no significant 
association among the duration of the disease and the QOL of the patients with T2DM, p = 
0.596. Result of statistical analysis also proved that there was no significant difference in the 
average value of the QOL between patients with and without complications, p = 0.446. 
Complications that may affect the QOL of patients with T2DM include increased blood 
cholesterol, hypertension, urinary tract infection, cardiovascular disease, nephropathy, 
retinopathy, and neuropathy.  
 
4. Discussions 
The present study found that the age of the T2DM patients was 59.70 ± 10.44 (years). Most of 
them (66%) were females. This result was not consistent with the sex ratio of the total 
Indonesian population which is 101.42 males per 100 females of the same year [10]. 
Additionally, a study proved that females were more prone to develop diabetes because they 
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have a greater chance to increase body mass index compared to males. Also, monthly 
premenstrual cycle syndrome and post-menopausal ease the fat accumulate in the body as a 
result of the hormonal process. These conditions tend to cause higher risk (53.2%) for 
developing T2DM in females compared to males [11]. A study undertaken in the US also 
proved that body mass index is a substantial contributor to the increase in the prevalence of 
diabetes [12]. A large-scale prospective cohort study conducted in Spain also proved that the 
incidence of T2DM increased with the increasing incidence of obesity [13]. 
By age, most of the T2DM patients were at the age range of 56-65 years and older. This finding 
is consistent with the statement of the American Diabetes Association, that people at the age of 
45 years or older have a high risk to developT2DM[14]. Aging affects many hormones that 
regulate metabolism, reproduction and other body functions. Aging affects the pancreatic β cell 
sensitivity to glucose and delay the mediationof glucose uptake by insulin into the cells[15]. 
 
Four of the most frequently provided antihyperglycemic drugs provided to the patients with 
T2DM with decreasing order were glibenclamide, glibenclamide-metformin, glimepiride and 
metformin. Glibenclamide is included into sulfonylurea class whose mechanism of action to 
increase insulin secretion by pancreatic beta cells so as to have a hypoglycemic effect. This drug 
is an option for adult patients with DM with normal weight who have never experienced 
ketoacidosis. A previous study conducted in a tertiary care teaching hospital in Eastern India 
indicated that the most widely used antihyperglycemic agent was biguanide followed by 
sulfonylureas [16]. Another study proved that the most widely used antihyperglycemic agent 
was metformin followed by sulfonylurea class of drugs [17]. These studies indicated that the 
utilization of antihyperglycemic agents vary from one country to another. 
 
The present study found that the index of QOL of patients with T2DM was 0.79. There were 
limited similar studies conducted in Indonesia.   A QOL study conducted on Brunai Malay 
T2DM patients (n=154) applying EQ5D5L found that the index of their QOL was 0.626 [18]. 
The QOL of patients with T2DM is an important and measurable outcome of healthcare 
interventions. It should be considered by policy-makers to prioritize the use of health resources. 
It was found in this study that the QOL of the patients was not associated with their education. 
In fact, only 20% of them graduated from universities. This is probably the reason why there 
was no association between the patients‟ education and their QOL. The level of education can 
affect the patients‟ insight in understanding the disease, self-care and lifestyle settings. In 
addition, the highly educated patients can easily develop a good understanding of information. 
These individuals will positively respond the information and take appropriate action for 
themselves [5]. An ancillary observational analysis of a four-year randomized controlled trial on 
T2DM patients had greater remission compared with an intensive lifestyle intervention (ILI) 
with a diabetes support and education control condition (DSE) among 4503 US adults [19]. 
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The duration of the disease by age groups of the patients was not associated with their QOL. In 
contrast to this study, previous finding indicated that the risk for complications in patients with 
DM was associated with the duration of the disease. The main risk factors for developing 
complications in diabetic patients were the duration and severity of the disease. Efforts to 
improve the QOL are important to prevent from long-term complications [20].The present study 
proved that there was no significant association between the age of the patients with T2DM and 
their QOL. 
 
This study proved that gender was not associated with the QOL of the patients with T2DM. A 
similar study also confirmed that there was no significant difference in the QOL of males and 
those of females [21]. Adherence to pharmacological and non pharmacological therapies 
contributes to improve the QOL of patients with T2DM. Females usually have better adherence 
to their treatments, thus, the treatment implementation usually goes on better in females 
compared to males. However, males tend to have higher self confidence and the ability to cope 
with the disease they suffer. Ultimately, gender was not associated with the level of QOL[21]. 
 
It was also proved that occupation, the disease duration, and age groups of the patients were not 
associated with their QOL.This study also indicated that there was no significant difference in 
the average value of the QOL between patients with and without complications. In contrast to 
this study, a finding proved that the complications experienced by the T2DM patients resulted in 
physical, psychological and even social limitations which ultimately lead to poor QOL[21]. 
 
5. Conclusions 
Most of the patients with T2DM were females with varies age ranging from 36 years to older 
than 65 years. Glybenclamide was the most widely provided antihyperglycemic drug to the 
patients with T2DM. The QOL of the patients was only 79% of full health. The most frequently 
observed dimensions of 11121 with a score of 0.80. The QOL of the patients was not associated 
with age, gender, education, occupation, complications as well as the disease duration. 
 
This study was limited by the small sample size and period of the patients‟ admission from 
which data were extracted. In the future a large-scale study is required to get more accurate 
results. 
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